ARS Pharmaceuticals, Inc. Share Price
NASDAQ: SPRY | Small CapARS Pharmaceuticals, Inc. Stock Performance
ARS Pharmaceuticals, Inc. Share Price Today
As of 9 October 2026, ARS Pharmaceuticals, Inc.'s share price is $4.57. The stock opened at $4.30, compared to its previous close of $4.36. During today's trading session, ARS Pharmaceuticals, Inc.'s share price traded between $4.21 and $4.63, with an average price of $4.42. Over the past 52 weeks, the stock has recorded a high of $13.14 and a low of $3.98. In terms of performance, ARS Pharmaceuticals, Inc.'s share price has declined by 44.61% over the last six months and is down 48.88% on a year-on-year basis.
ARS Pharmaceuticals, Inc. Share Price Chart
ARS Pharmaceuticals, Inc. Quarterly Profit & Loss
All figures in USD
ARS Pharmaceuticals, Inc. Annual Profit & Loss
All figures in USD
About ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.
ARS Pharmaceuticals, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $4.36 | $4.58 | +5.89% |
Sep 2026 | $5.99 | $4.33 | -28.07% |
Aug 2026 | $5.02 | $6.02 | +17.81% |
Jul 2026 | $8.01 | $5.11 | -36.20% |
Jun 2026 | $9.25 | $8.01 | -11.69% |
May 2026 | $8.28 | $9.07 | +9.94% |
Apr 2026 | $8.18 | $8.25 | +2.75% |
Mar 2026 | $8.99 | $8.03 | -13.67% |
Feb 2026 | $10.00 | $9.30 | -7.09% |
Jan 2026 | $11.52 | $10.01 | -14.15% |
Dec 2025 | $9.37 | $11.66 | +22.35% |
Nov 2025 | $9.01 | $9.53 | +6.60% |